Therapy News and Research

RSS
Monash study reveals why older people have reduced immune responses to cancer therapy

Monash study reveals why older people have reduced immune responses to cancer therapy

Hypnosis may help reduce fear, anxiety in children undergoing treatment for cancer

Hypnosis may help reduce fear, anxiety in children undergoing treatment for cancer

Clinical trial targets metastatic colorectal cancer with new combination therapy

Clinical trial targets metastatic colorectal cancer with new combination therapy

SetPoint announces positive long-term results of bioelectronic medicine to treat rheumatoid arthritis

SetPoint announces positive long-term results of bioelectronic medicine to treat rheumatoid arthritis

Can-Fite provides update on Phase II clinical trial with drug candidate Namodenoson

Can-Fite provides update on Phase II clinical trial with drug candidate Namodenoson

After opioid overdose, only 30 percent get medicine to treat addiction

After opioid overdose, only 30 percent get medicine to treat addiction

Scientists create universal assembly method to enhance cancer therapy and diagnostics

Scientists create universal assembly method to enhance cancer therapy and diagnostics

Microbiotica partners with University of Adelaide to develop defined bacterial product for ulcerative colitis

Microbiotica partners with University of Adelaide to develop defined bacterial product for ulcerative colitis

Study: Rheumatoid Arthritis patients with depression have increased risk of disease flare

Study: Rheumatoid Arthritis patients with depression have increased risk of disease flare

Study finds elevated risk of congenital defects in lithium-exposed infants

Study finds elevated risk of congenital defects in lithium-exposed infants

Scientists develop novel computational framework to support personalized cancer treatment

Scientists develop novel computational framework to support personalized cancer treatment

WHO releases new International Classification of Diseases (ICD-11)

WHO releases new International Classification of Diseases (ICD-11)

Scientists point to potentially promising treatment target for deadly brain cancers

Scientists point to potentially promising treatment target for deadly brain cancers

BIDMC scientists develop new tool to benefit patients with HCV-associated liver failure

BIDMC scientists develop new tool to benefit patients with HCV-associated liver failure

Radiation therapy alone may be enough to treat older, sicker patients with anal cancers

Radiation therapy alone may be enough to treat older, sicker patients with anal cancers

Study combines gene editing and stem cell technologies to predict person’s risk for heart disease

Study combines gene editing and stem cell technologies to predict person’s risk for heart disease

Study finds increased risk of mortality in people with cold agglutinin disease in five years after diagnosis

Study finds increased risk of mortality in people with cold agglutinin disease in five years after diagnosis

Innovative drugs and new European treatment guidelines refine, improve MS therapy

Innovative drugs and new European treatment guidelines refine, improve MS therapy

Scientists to focus on big data and genetics to identify risk factors for dementia

Scientists to focus on big data and genetics to identify risk factors for dementia

Mechanical thrombectomy appears to be important therapy for acute stroke in very old patients

Mechanical thrombectomy appears to be important therapy for acute stroke in very old patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.